Literature DB >> 21565645

Cilostazol: a potential therapeutic option to prevent in-stent restenosis.

Jamil B Dihu, Islam Abudayyeh, Hammad A Saudye, Ravi Gurujal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21565645     DOI： 10.1016/j.jacc.2011.01.022

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

1.  Cilostazol prevents progression of asymptomatic carotid artery stenosis in patients with contralateral carotid artery stenting.

Authors:  T Kato; H Sakai; T Takagi; Y Nishimura
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-09       Impact factor: 3.825

2.  Augmented AMPK activity inhibits cell migration by phosphorylating the novel substrate Pdlim5.

Authors:  Yi Yan; Osamu Tsukamoto; Atsushi Nakano; Hisakazu Kato; Hidetaka Kioka; Noriaki Ito; Shuichiro Higo; Satoru Yamazaki; Yasunori Shintani; Ken Matsuoka; Yulin Liao; Hiroshi Asanuma; Masanori Asakura; Kazuaki Takafuji; Tetsuo Minamino; Yoshihiro Asano; Masafumi Kitakaze; Seiji Takashima
Journal:  Nat Commun       Date:  2015-01-30       Impact factor: 14.919

3.  Effect of pioglitazone on in-stent restenosis after coronary drug-eluting stent implantation: a meta-analysis of randomized controlled trials.

Authors:  Ming-duo Zhang; Yu-hui Zhang; En-jun Zhu; Shi-bin Qiao; Shu-zheng Lv; Quan-ming Zhao
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.